Bonesupport names new member to executive team to boost North American presence: 5 insights

Megan Wood -   Print  |

Sweden-based Bonesupport appointed Patrick O'Donnell general manager and executive vice president of North American commercialization.

Here are five insights:


1. In his new role, Mr. O'Donnell will work with the company's partner, Zimmer Biomet, to expand sales of Bonesupport's Cerament Bone Void Filler.


2. Mr. O'Donnell will also be in charge of introducing Cerament G, a gentamicin eluting bone graft substitute, to the U.S. market, following trial outcomes.


3. Researchers will test Cerament G in the FORTIFY pre-market approval trial.


4. Prior to taking on this role, Mr. O'Donnell co-founded and served as CEO of ProteoThera, based in Cambridge, Mass.


5. Bonesupport offers injectable bioceramic bone graft substitutes to treat bone voids.


More articles on devices:
Where do our nation's politicians stand on the medical device tax?
Zimmer Biomet, Stryker, Wright Medical Group & more: 12 key notes
K2M exceeds estimates with Q3 2016 earnings — 5 highlights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers